Inventor
STUEBER WERNER
DE28 patents
⚠️ This page may combine multiple inventors who share the name “STUEBER WERNER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEHRINGWERKE AG
20 patentsUS5478810ADec 26, 1995
Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors
BEHRINGWERKE AG43 citations95
US5116962AMay 26, 1992
Material for affinity chromatography which is a sulfated polysaccharide bonded to an insoluble polymer
BEHRINGWERKE AG52 citations94
US5981697ANov 9, 1999
Synthetic peptides, antibodies against them and their use
BEHRINGWERKE AG19 citations92
US5607858AMar 4, 1997
Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors
BEHRINGWERKE AG25 citations92
US5599678AFeb 4, 1997
Antibodies which react with fibrinogen fragments E1, E2 and E3 and methods of their use
BEHRINGWERKE AG28 citations92
US4927809AMay 22, 1990
Oligopeptidyl nitrile derivatives, agents containing them and their use
BEHRINGWERKE AG26 citations92
US5274098ADec 28, 1993
Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them
BEHRINGWERKE AG20 citations82
US5204240AApr 20, 1993
Method and a kit containing means for the kinetic determination of factor xiii
BEHRINGWERKE AG9 citations74
US4713369ADec 15, 1987
Oligopeptidylargininol derivatives and their homologs, a process for their preparation, their use and agents containing them
BEHRINGWERKE AG17 citations74
US5202416AApr 13, 1993
Protease absorbent for isolating and purifying proteases, a process for the preparation therefor, and the method for purifying a protease
BEHRINGWERKE AG17 citations72
US5071954ADec 10, 1991
Synthetic prothrombin peptides and antibodies directed against them
BEHRINGWERKE AG12 citations72
US5859185AJan 12, 1999
HCMV-specific peptides, agents therefor and the use thereof
BEHRINGWERKE AG6 citations71
US5571844ANov 5, 1996
Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
BEHRINGWERKE AG11 citations71
US5049506ASep 17, 1991
Proline-containing decapeptides as substrates for factor XIII
BEHRINGWERKE AG5 citations63
US5556941ASep 17, 1996
Glycopeptide derivatives, a process for their preparation and pharmaceutical agents containing these compounds
BEHRINGWERKE AG3 citations62
US5334506AAug 2, 1994
Chromogenic method of detecting endoproteases
BEHRINGWERKE AG4 citations62
US5097014AMar 17, 1992
Chromogenic tripeptides
BEHRINGWERKE AG3 citations62
US5254672AOct 19, 1993
Synthetic peptides which contain sequences from factor VIIa, and the use thereof
BEHRINGWERKE AG2 citations61
US5047506ASep 10, 1991
Method for the purification of factor XIII by affinity chromatography
BEHRINGWERKE AG3 citations61
US5744298AApr 28, 1998
DNA sequences which encode immunoreactive HCMV-specific peptides
BEHRINGWERKE AG4 citations60
DADE BEHRING MARBURG GMBH
5 patentsUS6566085B1May 20, 2003
Synthetic peptides, antibodies directed against them, and the use thereof
DADE BEHRING MARBURG GMBH3 citations61
US6441141B1Aug 27, 2002
Synthetic peptides, antibodies against them and their use
DADE BEHRING MARBURG GMBH0 citations52
US6538113B1Mar 25, 2003
Methods of obtaining antibody directed against prothrombin fragments F2/F1+2
DADE BEHRING MARBURG GMBH0 citations51
US6932968B1Aug 23, 2005
Erythropoietin (EPO) peptides and antibodies directed against these
DADE BEHRING MARBURG GMBH1 citations50
US6143493ANov 7, 2000
HCMV-specific peptides, agents therefor and the use thereof
DADE BEHRING MARBURG GMBH0 citations49